A resolution supporting the goals and ideals of World Malaria Day.
This Senate resolution expresses official support for World Malaria Day and affirms that fighting malaria is in the national interest of the United States. It underscores malaria’s continuing global toll, including that progress has stalled in recent years, and highlights the vulnerability of young children and pregnant women. The measure notes the United States’ historical leadership through the President’s Malaria Initiative (PMI) and the Global Fund, and it endorses renewed efforts to reduce malaria incidence and deaths—targeting at least a 90% reduction by 2030. It also endorses ongoing public-private partnerships, greater local ownership of malaria programs in endemic countries, and continued U.S. leadership in global malaria reduction. This resolution is non-binding and serves as a statement of congressional intent and support for international malaria control efforts, linking global health progress to U.S. safety, stability, leadership, and prosperity.
Key Points
- 1Recognizes World Malaria Day (April 25) and malaria as a preventable yet deadly disease affecting many countries, with a disproportionate impact on young children and pregnant women.
- 2Highlights progress achieved since 2000, credits U.S. leadership (PMI and the Global Fund), and notes that global malaria cases and deaths rose to 2023 levels despite prior gains.
- 3Emphasizes tools and innovations in the malaria fight (e.g., bed nets, diagnostics, vaccines for children, spatial repellents, and gene-drive technologies) and the threats posed by resistance and conflict.
- 4Sets a policy goal to reduce malaria case incidence and mortality by at least 90 percent by 2030.
- 5Commends endemic countries’ efforts and supports moving toward local ownership and eventual self-sufficiency in malaria programs.
- 6Encourages public-private partnerships and reaffirmed U.S. leadership through PMI and the Global Fund to Help Fight AIDS, Tuberculosis and Malaria.